• About
  • Culture
  • Tags
  • Details
location-icon
Tokyo
person-icon
51-250

CureApp develops evidence-based medical programs, “Digital Therapeutics (DTx),” for patients who suffer from conditions that conventional treatment methods with drugs or devices were not effective. Our pipeline includes nicotine addiction, hypertension, NASH liver disease, alcoholism, cancer treatment, and respiratory/cardiovascular conditions.

Our approach is centered around a new field of medicine designed to approach the root cause of health conditions using mobile applications. Our method works by modifying how users understand and think about their conditions (cognitive change) and by changing their lifestyle gradually (behavioral change) to treat the conditions.

View CureApp's company page

CureApp Detailed Data

Founding Date
2014
Global Employee Count
51-250
Global Headquarters
Tokyo
Global Offices
  • US (Sunnyvale CA)
Japan Headquarters
Tokyo
Funding Status
JPY 13.4 billion in total
Public Status
Private

↑ Back to top ↑